These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 7688445

  • 1. [The triple-serum test for detection of Down syndrome and neural tube defects; the problem of a risk assessment test].
    van den Boer-van den Berg JM, Dupuis HM.
    Ned Tijdschr Geneeskd; 1993 Jun 26; 137(26):1286-9. PubMed ID: 7688445
    [No Abstract] [Full Text] [Related]

  • 2. [Triple test: problem or enhancement of prenatal diagnosis].
    Rauskolb R, Engel W.
    Z Geburtshilfe Neonatol; 1995 Jun 26; 199(3):91. PubMed ID: 7553260
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Tri-test: clinical considerations on 1784 cases].
    Caserta D, Baldi M, Carta G, Moscarini M.
    Minerva Ginecol; 1998 Mar 26; 50(3):73-5. PubMed ID: 9595918
    [Abstract] [Full Text] [Related]

  • 5. Maternal serum screening.
    Carroll JC.
    Can Fam Physician; 1994 Oct 26; 40():1756-64. PubMed ID: 7524838
    [Abstract] [Full Text] [Related]

  • 6. Maternal serum screening of Palestinian women in the West Bank.
    Husseini A, Akkawi M.
    East Mediterr Health J; 2005 Jul 26; 11(4):824-7. PubMed ID: 16700399
    [Abstract] [Full Text] [Related]

  • 7. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies.
    Frishman GN, Canick JA, Hogan JW, Hackett RJ, Kellner LH, Saller DN.
    Obstet Gynecol; 1997 Jul 26; 90(1):98-101. PubMed ID: 9207822
    [Abstract] [Full Text] [Related]

  • 8. New triple screen test for Down syndrome: combined urine analytes and serum AFP.
    Bahado-Singh RO, Oz U, Kovanci E, Cermik D, Flores D, Copel J, Mahoney M, Cole L.
    J Matern Fetal Med; 1998 Jul 26; 7(3):111-4. PubMed ID: 9642606
    [Abstract] [Full Text] [Related]

  • 9. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS, Haverkamp AD, Stark CF, Haverkamp C, Barth CK.
    J Matern Fetal Med; 1996 Jul 26; 5(2):70-3. PubMed ID: 8796771
    [Abstract] [Full Text] [Related]

  • 10. [Maternal serum screening for detection of fetal chromosome abnormalities].
    Holzgreve W, Miny P, Schloo R, Tercanli S.
    Gynakologe; 1995 Oct 26; 28(5):280-8. PubMed ID: 7498824
    [No Abstract] [Full Text] [Related]

  • 11. Triploidy identified through second-trimester serum screening.
    Huang T, Alberman E, Wald N, Summers AM.
    Prenat Diagn; 2005 Mar 26; 25(3):229-33. PubMed ID: 15791661
    [Abstract] [Full Text] [Related]

  • 12. Ethnic origin and maternal serum markers of Down syndrome in Israel.
    Barkai G, Goldman B, Ries L, Chaki R, Cuckle HS.
    Prenat Diagn; 1996 Sep 26; 16(9):870-2. PubMed ID: 8905904
    [No Abstract] [Full Text] [Related]

  • 13. Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
    Rose NC, Mennuti MT.
    West J Med; 1993 Sep 26; 159(3):312-7. PubMed ID: 7694429
    [Abstract] [Full Text] [Related]

  • 14. [Specificity of biochemical markers of pregnancy second trimester].
    Salazar López R, Ibarra Gallardo AL, Iduma Meléndrez M, Leyva Bojórquez R.
    Ginecol Obstet Mex; 2007 Oct 26; 75(10):608-14. PubMed ID: 18800579
    [Abstract] [Full Text] [Related]

  • 15. Prenatal diagnosis using the triple test.
    Palka G, Guanciali Franchi P, Papponetti M, Marcuccitti J, Morizio E, Calabrese G, Stuppia L, Di Ilio C.
    Minerva Ginecol; 1998 Oct 26; 50(10):411-5. PubMed ID: 9866951
    [Abstract] [Full Text] [Related]

  • 16. Repeat testing in antenatal screening for Down syndrome using dimeric inhibin-A in combination with other maternal serum markers.
    Hackshaw AK, Wald NJ.
    Prenat Diagn; 2001 Jan 26; 21(1):58-61. PubMed ID: 11180243
    [Abstract] [Full Text] [Related]

  • 17. Biochemical screening tests for Down syndrome.
    Coetzee E, Viljoen D.
    S Afr Med J; 1995 Feb 26; 85(2):72-3. PubMed ID: 7541163
    [No Abstract] [Full Text] [Related]

  • 18. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
    Benn PA, Ying J, Beazoglou T, Egan JF.
    Prenat Diagn; 2001 Jan 26; 21(1):46-51. PubMed ID: 11180240
    [Abstract] [Full Text] [Related]

  • 19. Refinements in managing maternal weight adjustment for interpreting prenatal screening results.
    Neveux LM, Palomaki GE, Larrivee DA, Knight GJ, Haddow JE.
    Prenat Diagn; 1996 Dec 26; 16(12):1115-9. PubMed ID: 8994247
    [Abstract] [Full Text] [Related]

  • 20. Interference in an unconjugated estriol assay causing a false negative integrated prenatal screening report.
    Dennis AW, Siu VM, Campagnolo C, Soldin SJ.
    Prenat Diagn; 2010 Feb 26; 30(2):165-7. PubMed ID: 20020420
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.